Records containing: Melanoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2020-11-05
Characterization of Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
CLINICAL_TRIALS study record update · 2020-10-30
Transfer of Genetically Engineered Lymphocytes in Melanoma Patients: A Phase 1 Dose Escalation Study
CLINICAL_TRIALS study record update · 2020-10-29
Randomized Phase II Study of Multipeptide Vaccination With or Without Regulatory T Cell Depletion Using Ontak in Patients With Metastatic Melanoma
CLINICAL_TRIALS study record update · 2020-10-28
Sun Exposure and Melanoma in Agricultural Workers
CLINICAL_TRIALS study record update · 2020-10-20
Sentinel Node Localisation and Staging With Superparamagnetic Iron Oxide-enhanced MRI and Magtrace®/Sentimag® in Patients With Malignant Melanoma of the Extremities. The MAGMEN Feasibility Study
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2020-10-19
A Phase I/IIa Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients With Advanced, Unresectable Solid Tumors
CLINICAL_TRIALS study record update · 2020-10-12
A Phase 1b Trial of Talimogene Laherparepvec in Combination With Dabrafenib and Trametinib in Advanced Melanoma With an Activating BRAF Mutation
CLINICAL_TRIALS study record update · 2020-10-12
Does PREVENA Vacuum-assisted Closure Reduce Lymphorrhoea Compared to Conventional Wound Closure After Axillary and Inguinal Lymph Node Dissection in the Management of Metastatic Cutaneous Skin Tumors ?
CLINICAL_TRIALS study record update · 2020-09-30
The Effect of BRAF Inhibition With Vemurafenib On The Innate and Adaptive Immune Systems in Patients With Unresectable Stage III or Stage IV Melanoma Expressing a V600 BRAF Mutation
CLINICAL_TRIALS study record update · 2020-09-18
An International Multicenter Open-label Randomized Trial of the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of BCD-100 (JSC BIOCAD, Russia) as Monotherapy in Patients With Unresectable/Metastatic Melanoma.
CLINICAL_TRIALS study record update · 2020-09-17
A Phase 1 Study of SGN-CD47M in Patients With Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2020-09-16
Melanoma Risk-Reduction Practices Among Melanoma Patients and Their Family Members
CLINICAL_TRIALS study record update · 2020-09-11
A Prospective Multicenter Cohort Study of Late Physical Psychological and Social Effects in Patients Treated With Ipilimumab for Advanced Melanoma
CLINICAL_TRIALS study record update · 2020-09-02
Phase I / II Study of the Combination of Doxycycline With Temozolomide and Ipilimumab in Patients With Metastatic Melanoma
CLINICAL_TRIALS study record update · 2020-08-28
Feasibility and Safety Profile of a 3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma
CLINICAL_TRIALS study record update · 2020-08-27
A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
CLINICAL_TRIALS study record update · 2020-08-20
Phase 2 Trial of SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
CLINICAL_TRIALS study record update · 2020-08-20
Safety and Efficacy of Blood Brain Barrier Opening With Implantable Device Sonocloud® Combined With Nivolumab Used Alone or an Association With Ipilimumab in Brain Metastases From Patients With Malignant Melanoma
CLINICAL_TRIALS study record update · 2020-08-10
Development of BioForte Technology for in Silico Identification of Valuable Genomic Features That Are Candidates for Microbiome-based Therapeutics and Diagnostics.
CLINICAL_TRIALS study record update · 2020-08-10
An Open-Label, Phase 1, Dose Escalation Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Melanoma
CLINICAL_TRIALS study record update · 2020-08-03
A Phase I Trial Testing Mart-1 Peptide Immunization in Malignant Melanoma
CLINICAL_TRIALS study record update · 2020-07-30
Molecular Characterisation of Serial Tumour Samples and Their Correlation With Circulating Biomarkers and Other Biospecimens Taken During the Clinical Course of Patients Receiving Treatment for Malignant Melanoma.
CLINICAL_TRIALS study record update · 2020-07-20
Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?
CLINICAL_TRIALS study record update · 2020-07-15
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
CLINICAL_TRIALS study record update · 2020-07-07
A Phase 1b Trial of X4P-001 Alone and With Pembrolizumab in Patients With Advanced Melanoma